MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2024 International Congress » Parkinsonism, Others

Meeting: 2024 International Congress

24-Hour Ambulatory Blood Pressure Monitoring and Dipping Patterns in Parkinson’s Disease and Multiple System Atrophy

D. Tunjungsari, M. Hildaria, I. Jeremia, A. Jody, C. Kathy, A. Tiksnadi (Central Jakarta, Indonesia)

A Cross-Sectional Study of Sleep Disturbances in Parkinson’s Disease Patients at a Tertiary Neurological Center in Nepal

AYU. Chandra, AVI. Chandra (Tianjin, China)

Assessing Feasibility of Using Phone Video Data in Diagnosing Parkinsonism

Z. Ahmed, S. Desai, A. Deb, S. Roy, D. Desai (Worcester, USA)

Association between Antiepileptic Drugs and Parkinson’s Disease: A Strong or Weak Link?

S. Kharel, SS. Shrestha, SA. Acharya, R. Ojha (Kathmandu, Nepal)

Atypical Parkinsonism Secondary to Recurrent Deep Vein Thrombosis with Associated Intracranial Dural Fistula

C. Gómez López-de-San-Román, DM. Cerdán Santacruz, M. Capra, L. Caballero Sánchez, I. Bermejo Casado, A. Castrillo Sanz, A. Mendoza Rodríguez, G. Suárez Fernández, P. Guerrero Becerra, M. Vargas Cobos, C. Tabernero Garcia (Segovia, Spain)

Behind the wheel with Parkinson’s-Older patients’ review

M. Khwaja, G. Pun, T. Nanayakkara, R. Miah, A. Chatterjee, N. Butt, T. Zubair (Reading, United Kingdom)

Body Mass Index as a Possible Poor Prognostic Factor in Motor and Postural Condition Through the Evaluation of MDS-UPDRS 3.3 – 3.18 in Patients with Parkinson’s.

C. álvarez-Hernández, R. Baños-Betancourt, K. Velazquez-Roman, G. Rivera-Monroy, A. Guerra-Anzaldo, W. Moguel-Cardín, A. Domínguez-García, D. Romero-Terán, A. Regalado-Mustafá, J. Delgado-Uriarte, N. Moreno-Aldama, A. Uribe Leon, M. Unda-Mcfarlane, A. Cervantes-Arriaga, M. Rodriguez-Violante, D. Luna-Escamilla, K. Gonzalez-Rosas, U. Ugalde-Miranda, F. Moralez-Gonzalez, M. Cabrera-Jimenez (Mexico City, Mexico)

Broadening the Spectrum of Movement Disorders in Steroid-responsive Encephalopathy associated with Autoimmune Thyroiditis

M S. Majoul, R. Zouari, A. Rachdi, M Z. Saied, D. Ben Mohamed, F. Nabli, S. Ben Sassi (Tunis, Tunisia)

Case Report: An Unusual Case of Corticobasal Syndrome

A. Ly, M. King, C. Sherer, J. Crook, A. Schindler, L. Danielian, K. Porter, A. Snyder, J. Kwan, S. Scholz (Bethesda, USA)

Changes in Postural Control of Patients with Normal Pressure Hydrocephalus After Lumbar Puncture

Z. Kosutzka, I. Straka, L. Hapakova, J. Pucik, M. Saling (Bratislava, Slovakia)

Characterization of Autoimmune Parkinsonism. A case series

W. Trillo Alvarez, C. Ibañez Escalante, A. Escalante Mercado, P. Bermejo Rosado, L. Delgado Villanueva, A. Aquino Toledo, R. Huanca Machon (Arequipa, Peru)

Clinical Utility of Synuclein Skin Biopsy in the Initial Diagnosis and Evaluation of Parkinsonian Disorders

J. Isaacson, R. Freeman, C. Gibbons, A. Alshehri (Boston, USA)

Coat test: a bedside timed test for quantifying motor function in Parkinson’s disease patients.

C. Holgado, M. Wilken, G. Lopez, M. Merello (Buenos Aires, Argentina)

Cognitive Side Effects to Initial Levodopa Exposure as a “Red Flag”: A Retrospective Study

A. Huang, A. Wise, V. Shanker (New York, USA)

Comparison of Composite Method Calculations for Monitoring Disease Progression in Early Parkinson’s Disease

M. Czech, L. Yang, J. Shen, M. Crouthamel, T. Kangarloo, J. Adams, R. Dorsey, J. Cosman (North Chicago, USA)

Delayed Parkinsonism as a Delayed Neurological Sequele in Carbon Monoxide Intoxication: A Rare Case Report

CP. Gasmara, A. Tiksnadi, D. Tunjungsari (DKI Jakarta, Indonesia)

Disease-related comprehensive motor pattern derived from 2D single RGB video as a biomarker for early and prodromal Parkinson disease

JH. Shin, SM. Lee, CH. Jeong, R. Yu, SH. Ha, S. Kim, B. Jin, KA. Woo, KY. Jung, JY. Lee, HJ. Kim, B. Jeon (Seoul, Republic of Korea)

Driving assessment in older patients with Parkinson’s in United Kingdom.

M. Khwaja, T. Nanayakkara, G. Pun, R. Miah, N. Butt, A. Chatterjee (Reading, United Kingdom)

Early-onset Parkinsonism as Presenting Manifestation of CADASIL in a Mexican Woman with NOTCH3 c.1732C>T Pathogenic Variant

M. Arbeu Reyes, B. Madariaga Cortés, S. Castillo Torres (Puebla, Mexico)

Exploring Retrospectively the Predisposing Factors of Sleep Disorders in Parkinson’s Disease.

SF. Arechavala Lopez, I. Fuentes Calvo, AJ. Hernández-Medrano, A. Cervantes-Arriaga, M. Rodríguez-Violante (CDMX, Mexico)

Giant Aneurysm Causing Parkinsonism and REM Sleep Disorder

A. Falcone, I. Brum, F. Freua, E. Barbosa, R. Cury, J. Parmera (Sao Paulo, Brazil)

Hospital Care Learning Collaborative: Sharing strategies to address the Parkinson’s Foundation Inpatient Clinical Care Standards

A. Brooks, E. Buetow, H. Azmi, B. Walter, K. Amodeo, P. Pronovost (Miami, USA)

Identifying key symptoms associated to parkinsonism other than Parkinson’s Disease: a case series

M. Gaitan-Palau, C. Armengol-Garcia, D. Martinez-Ramirez (Monterrey, Mexico)

Immune cell traits and Parkinson’s disease: A Mendelian randomization study

JL. Wang, Y. Fang, YL. Li, R. Zheng, Y. Chen, J. Tian, XZ. Yin, JL. Pu, BR. Zhang (Hangzhou, China)

Immunomodulatory Effects Of Covid-19 Vaccination On Inflammatory And Neurotrophic Factors In Parkinson’s Disease: Insights From Clinical Subtypes

J. Salimjonov, N. Rashidova, KH. Khalimova, R. Matmurodov (Tashkent, Uzbekistan)

Impact of Striatal Degeneration on Clinical Phenotype in Idiopathic Normal Pressure Hydrocephalus: A Comparative Analysis

K. Badiola-Lim, Q. Hu, N. Prakash (Summit, USA)

Impact of Striatal Degeneration on Patient Reported Symptoms in Idiopathic Normal Pressure Hydrocephalus

Q. Hu, K. Badiola-Lim, D. Karimeddini, C-L. Kuo, N. Prakash (Farmington, USA)

Influence of immigration on Parkinson’s disease: analysis of clinical presentation.

A. Peral Quirós, N. Caballol Pons, A. Planas Ballvé, M. Balagué Marmaña, MI. Gómez Ruiz, A. ávila Rivera (Barcelona, Spain)

Initial Results After Launch of Best Practice Advisory for Contraindicated Agents in Parkinson’s Disease and Related disorders

N. Shah, N. Chunga, K. Amodeo, I. Richard (Rochester, USA)

Integrating Parkinson’s Plus Cohorts into the Global Parkinson’s Genetics Program

D. Vaughan, M. Theilmann Jensen, O. Serrano Asensio, T. Tharmaraja, S. Jasaityte, E. Stafford, H. Houlden, A. Huey Tan, S. Lim, H. Morris, GP2. Genetics Program (London, United Kingdom)

Manganese-induced Parkinsonism Vs Rotenone-induced Parkinsonism: Animal Life Matters!

S. Chib (Bathinda, India)

Mitigating The Impact Of Covid-19 On Parkinson’s Disease: Insights From Vaccination Strategies

J. Salimjonov, KH. Khalimova, N. Rashidova, R. Matmurodov (Tashkent, Uzbekistan)

Mixed Brain Pathology in Neurodegenerative Parkinsonism and Dementia

K. Mensikova, L. Tuckova, D. Hrabos, A. Jawad, P. Kanovsky (Olomouc, Czech Republic)

New onset movement disorders following COVID-19 infection

D. van Wamelen, B. Facer, S. Rota, M. Bonello, K. Chaudhuri, G. Breen, B. Michael (London, United Kingdom)

Non motor symptoms assessment in Primary Familial Brain Calcification, survey on a cohort

G. Bonato, M. Carecchio (Padova, Italy)

Normal pressure hydrocephalus in two Parkinson’s disease patients with deep brain stimulation – co-occurrence or complication

B. Borgohain, S. Kola, M. Karri, R. Alugolu, R. Kandadani (Hyderabad, India)

Pallidotomy as a Therapeutic Option for Patients with Advanced Parkinson’s Disease: Case Study

R. Pessoa, L. Cidral, E. de Souza, M. Marchiori (Curitiba, Brazil)

Parkinson Disease. An innovative Aproach

M. Martinovic, G. Montado, R. Aljanati (Montevideo, Uruguay)

Parkinsonism Associated with Twinkle Gene Mutation

C. Felin, B. Oliveira, Y. Borges, S. Trentin (Porto Alegre, Brazil)

Parkinsonism due to Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Responsive to Carbidopa/Levodopa

P. Hoff, F. Butt (Oklahoma City, USA)

Parkinsonism in setting of hypoparathyroidism

R. Fekete (Hawthorne, USA)

Peripheral immunity and clinical phenotypes in patients with ventriculomegaly

C. Espinoza-Vinces, I. Avilés-Olmos, G. Martí-Andrés, M. Jiménez-Vázquez, M. Calvo-Imirizaldu, M. Marín Gracia, R. Villino-Rodríguez, A. Atorrasagasti-Villar, J. Arbizu, MR. Luquin (PAMPLONA, Spain)

Perry Syndrome due to a DCTN1 novel variant

P. Lorenzo-Barreto, I. Muro-García, E. Casas-Peña, JP. Romero-Muñoz, L. López-Manzanares (Madrid, Spain)

PKG-Ethnicity project: An initial analysis of ethnical differences in Parkinson’s KinetoGraph (PKG) results between white and non-white ethnic groups

MA. Qamar, L. Batzu, D. Trivedi, K. Ray Chaudhuri (London, United Kingdom)

Post-stroke Movement Disorders: A Systematic Review of the Clinical Spectrum, Neuroanatomy, and Demographic Characteristics of 577 Published cases

B. Mishra, A. Agarwal, M. Nayak, N. Nilima, P. Srivastava, V. Vishnu (South delhi, India)

PSP-Like Syndrome Associated with Dysautonomic Findings as a Presentation of an Anti-Iglon5 Antibody-Related Encephalopathy

A. Gomez, MB. Charra Castellani, F. Knorre, D. Ballesteros, V. Kurtz (Buenos Aires, Argentina)

Quantitative Assessment of X-linked Dystonia-Parkinsonism Using Wearable Sensing Technology

G. Corniani, G. Del Duca, S. Sanseverino, N. Ganza, S. Begalan, C. Nelson, P. Acuna, C. Go, N. Sharma, P. Bonato, C. Stephen (Boston, USA)

Real-world use of biomarkers for Parkinsonism: Should I do this (pSyn) or DaT?

A. Martinez Nunez, N. Walker-Pizarro, A. Wagle Shukla, A. Ramirez-Zamora, N. Mcfarland (Gainesvile, USA)

Risk Factors Of Parkinson’s Disease A Case-Control Study In Tunisian Patients

S. Sellami, N. Farhat, KS. Moalla, N. Bouattour, S. Daoued, S. Sakka, M. Damak, C. Mhiri (Sfax, Tunisia)

SARS-CoV-2 induced neurodegeneration in oxidative stress and genetic models of Parkinson’s Disease

D. Chatterjee, T. Rodriguez, K. Crowther, M. Byrne, R. Smeyne (Philadelphia, USA)

Subdural Hematoma Leading to Subacute Secondary Parkinsonism

G. Ahmadi Jazi, P. Chen, S. Attaripour Isfahani (Orange, USA)

The Challenges of Very Late-Onset Parkinson’s Disease: Perspectives from Patients, Primary Caregivers and Attending Physicians.

S. Okusa, R. Okouchi, Y. Sakai, T. Nukariya, T. Tezuka, Y. Nihei, J. Nakahara, M. Seki (Tokyo, Japan)

The Differences in the Perception of Parkinson’s Disease-related Motor Complications between Patients and Physicians

T. Tezuka, R. Okochi, Y. Sakai, T. Nukariya, S. Okusa, Y. Nihei, J. Nakahara, M. Seki (Tokyo, Japan)

The Impact of Camp Lejeune Toxins on the Development of Parkinsonisms and Movement Disorders

K. Colletta, J. Hirschey, A. Raedy, A. Siddiqui, F. Weaver, S. Kletzel (Hines, USA)

The impact of stimulation setting on Battery Longevity in Deep Brain Stimulation

F. Yazdanian, A. Enriquez-Marulanda, N. Dehmamy, J. Shils, R. Alterman (boston, USA)

Trihexyphenidyl Use in a Parkinsonian Phenotype of Gerstman-Sträussler-Scheinker Syndrome

P. Atit, S. Aradi (Tampa, USA)

Unique Presentation of SPG 15 as Juvenile Levodopa Responsive Parkinsonism: A Case Report

D. Nayar, A. Boddu, T. Virmani (little rock, USA)

Vestibular impairment, turning direction and turn progression in Parkinson’s disease

C. Pongmala, M. van Emde-Boas, P. Kanel, N. Bohnen (Ann Arbor, USA)

« View all sessions from the 2024 International Congress.

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley